Hospital Ruber Internacional
HM Hospitales — este é um grupo de 7 principais clínicas espanholas localizadas em Madri (Espanha).
Especialização — oncologia adulta e pediátrica, neurologia, neurocirurgia, cardiologia e ortopedia.
Em 2018, 5 dos 7 hospitais foram incluídos no TOP das melhores clínicas privadas da Espanha segundo a Organização de Monitoramento de Reputação Médica MERCO.
Anualmente, os cirurgiões do HM realizam mais de 26.000 cirurgias, e cerca de 2.500 pacientes são tratados para câncer.
O Dr. Jaume Capdevila é um renomado especialista em câncer digestivo, com foco em tumores de pâncreas e intestino delgado. Ele possui formação internacional e é membro de diversas instituições de prestígio.
Mais de 900 procedimentos oncológicos realizados – A Dra. Buxó é especialista em cancros gastrointestinais no Centro Médico Teknon.
Especialista em carcinomatose peritoneal e cancros abdominais avançados no Centro Médico Teknon – um dos centros líderes em Espanha.
Dra. Lana Bijelic é especialista em carcinomatose peritoneal, formada sob a orientação do Prof. Paul Sugarbaker no Washington Hospital Center.
Most patients do not require an ostomy after small intestine resection. Surgeons usually perform an anastomosis to reconnect healthy tissue directly. A stoma is necessary only if the remaining intestine cannot be safely joined or requires time to heal after surgery.
Bookimed Expert Insight: Spanish centers like Hospital Quiron Barcelona and Centro Médico Teknon focus heavily on robot-assisted and minimally invasive methods. Dr. Antonio de Lacy Fortuny performs over 1,000 minimally invasive interventions annually. This high volume of specialized surgery often helps avoid ostomies by ensuring more precise bowel reconnections than traditional open surgery.
Patient Consensus: Patients note that even if a temporary bag is needed, the focus remains on the reversal procedure later. Many emphasize that clear communication with the surgical team about stoma placement before surgery helps reduce anxiety.
Leading Spanish hospitals for small intestine cancer include Centro Médico Teknon, Hospital Quirónsalud Barcelona, and Clínica Universidad de Navarra. These JCI-accredited facilities provide advanced diagnostics like PET-CT and specialized surgical interventions. Experts utilize multidisciplinary tumor boards to coordinate complex resections and targeted therapies.
Bookimed Expert Insight: Success in treating rare malignancies like small intestine cancer is often linked to surgical volume rather than general clinic size. Our data shows that top specialists like Dr. Antonio de Lacy Fortuny have performed over 15,000 procedures. Choosing a center with these high-volume practitioners ensures access to refined techniques like laparoscopic and transluminal surgery for better outcomes.
Patient Consensus: Patients emphasize the importance of seeking care at major university centers where multidisciplinary tumor boards review rare cases. They note that coordinating diagnosis, specialized surgery, and pathology under one roof significantly reduces stress during treatment.
Recognized experts for small intestine cancer in Spain include Dr. Jaume Capdevila at Centro Médico Teknon and Dr. Josep Tabernero at Hospital Quiron Barcelona. These specialists focus on rare gastrointestinal tumors. They utilize JCI-accredited facilities. They apply multidisciplinary protocols for complex orphan malignancies.
Bookimed Expert Insight: Patients seeking treatment for rare small bowel tumors should look for surgeons with specific experience in peritoneal carcinomatosis. While many oncologists treat general digestive issues, specialists like Dr. Lana Bijelic at Centro Médico Teknon bring unique training under pioneers like Dr. Paul Sugarbaker. This specific expertise is vital. High-volume centers in Barcelona typically manage 10,000 to 40,000 patients annually. This volume ensures teams are familiar with rare neuroendocrine and GIST presentations.
Patient Consensus: Patients emphasize the need for a second pathology review. They suggest choosing large academic centers in Barcelona or Madrid to ensure coordinated care between surgeons and geneticists.
Patients can access clinical trials for rare small-bowel cancers in Spain through major oncology centers in Barcelona, Madrid, and Pamplona. These institutions participate in international studies for targeted therapies and immunotherapies. Eligibility often requires specific molecular profiling and genetic markers like MSI-H or KRAS.
Bookimed Expert Insight: Spanish oncology networks are exceptionally integrated, centered in Barcelona and Madrid. Data shows clinics like Hospital Quiron Barcelona and Centro Médico Teknon manage high volumes of 10,000 to 40,000 patients yearly. This volume allows them to act as primary investigators in multicenter trials. Patients should choose centers affiliated with groups like TTD or GETHI to access niche studies not available elsewhere.
Patient Consensus: Patients note that clinical trial access is limited to large university hospitals. They emphasize getting molecular profiling done early as trials can close quickly once recruitment slots are filled.
Dietary changes involve eating 5 to 6 small meals every 2 to 3 hours to manage malabsorption. Patients should prioritize soft proteins and electrolytes while restricting insoluble fiber and high-fat foods. Specialized oncology centers in Spain often use multidisciplinary teams to manage these nutritional transitions.
Bookimed Expert Insight: Spanish oncology centers like Centro Médico Teknon and Hospital Quiron Barcelona often integrate nutritionists directly into surgical teams. This is vital because specialists like Dr. Antonio de Lacy Fortuny perform thousands of complex bowel procedures. Large clinics in Spain handle between 10,000 and 400,000 patients annually. This high volume ensures medical teams are exceptionally experienced in managing the metabolic shifts following a small intestine resection.
Patient Consensus: Patients note it is helpful to track which foods trigger symptoms rather than following rigid rules. Many find that shifting to lactose-free alternatives prevents digestive issues that often appear after treatment.